AMD chips from TSMC´s US fabs to cost more, but CEO touts resilience

AMD´s US-made chips will be priced up to 20% higher due to supply-chain security, according to CEO Lisa Su, emphasizing long-term value over immediate costs for crucial platforms like Artificial Intelligence.

AMD CEO Dr Lisa Su has stated that chips produced for AMD by TSMC in their United States facility will carry a price premium of 5% to 20% compared to those manufactured by TSMC in Taiwan. In an interview with Bloomberg, Su emphasized that while these higher costs may seem significant, the investment is justified by the strategic gains in supply-chain resilience. Drawing on lessons from the COVID-19 pandemic, Su highlighted how disruptions underscored vulnerabilities in global chip supply, creating costly ripple effects across industries dependent on advanced semiconductors.

TSMC´s Arizona-based manufacturing plant is at the forefront of this shift, operating its most advanced process at 4 nm using extreme ultraviolet lithography. The N4 series nodes—such as N4P—are a critical part of AMD´s portfolio, supporting the production of central processing units, graphics processors, field-programmable gate arrays, and a variety of specialized devices. Despite the operational cost gap between the US and Taiwan fabs, AMD believes the addition of a US-based supply line not only insulates the company from shocks but also aligns with broader national interests in technological independence.

Looking ahead, AMD is preparing a generational leap with its upcoming ´Zen 6´ family of CPUs, which will utilize TSMC’s new N2 (2 nanometer nanosheet) technology. This transition is expected to primarily impact the core complex dies for both desktop and server processors under the Ryzen and EPYC banners. Complementary input/output dies for these platforms, meanwhile, will advance to the TSMC N4P node from the current N6, signaling a dual-track approach to process advancement. As AMD navigates these transitions, Su´s message is clear: the added cost of local manufacturing is an investment in both long-term competitiveness and reliability in a world where secure and diversified supply chains have become strategic imperatives.

67

Impact Score

Anthropic Claude models on Vertex Artificial Intelligence

Vertex Artificial Intelligence provides fully managed access to Anthropic’s Claude models with streaming, logging, and flexible pricing. The catalog spans Sonnet, Opus, and Haiku tiers geared for agents, coding, research, and high-volume experiences.

Artificial intelligence guides personalized treatment for heart patients

An international team led by the University of Zurich used Artificial Intelligence to refine risk assessment in non-ST-elevation acute coronary syndrome, proposing a new GRACE 3.0 score that could better guide invasive treatment. The analysis spans data from more than 600,000 patients and suggests many should be reclassified.

Artificial intelligence is changing how clinicians quantify pain

Clinicians are testing artificial intelligence to turn pain into a measurable vital sign, from facial analysis apps in care homes to monitors in the operating room. Early deployments report fewer sedatives, calmer patients, and faster assessments, but questions about bias and context remain.

Big tech bets on BECCS as Kairos Power advances molten salt reactors

Tech giants are backing BECCS projects that capture paper mill emissions for deep geological storage, while Kairos Power pushes ahead with molten salt reactors. This edition also surveys a podcast on IVF embryo ethics and a slate of developments from Artificial Intelligence to autonomous vehicles.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.